|
Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
RECRUITINGSponsored by Santé Arménie French-Armenian Research Center
Actively Recruiting
SponsorSanté Arménie French-Armenian Research Center
Started2023-06-21
Est. completion2028-06-30
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05904301
Summary
Longitudinal prospective multicenter Armenian registry of systemic autoimmune, autoinflammatory diseases with constitution of bio-banking.
Eligibility
Healthy volunteers accepted
Inclusion Criteria: 1. Patients with a confirmed diagnosis of at least one of following autoimmune systemic diseases: Behcet disease, ANCA -positive vasculitis, Takayasu arteritis, Giant cell arteritis, Systemic sclerosis, Sjogren syndrome, Rheumatoid arthritis, Spondylarthritis (psoriatic, ankylosing, crohn's related), Angioedema hereditary and acquired, Pediatric dermatology, Autoinflammatory diseases (hereditary and acquired), Unexplained infertility, Immune thrombocytopenic purpura/ Autoimmune hemolytic anemia (ITP, AHA), Primary anti-phospholipid syndrome (APS), Celiac disease. 2. Age: major and minor 3. Patients who have been informed and provided with written informed consent to participate Or consent from legal representative Exclusion Criteria: 1. Patients refusing to participate in the registry 2. Non-consent from legal representative 3. Breastfeeding or pregnant patients
Conditions10
Antineutrophil Cytoplasmic Antibody (ANCA) Positive VasculitisArthritisBehcet DiseaseCeliac DiseaseGiant Cell ArteritisHereditary and Acquired AngioedemaPrimary Antiphospholipid SyndromeRheumatoid ArthritisSjogren's SyndromeTakayasu Arteritis
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorSanté Arménie French-Armenian Research Center
Started2023-06-21
Est. completion2028-06-30
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05904301